Nadine Tuaillon - Gettysburg PA, US Leslie Johnson - Darnestown MD, US Ezio Bonvini - Rockville MD, US Kathryn Stein - Potomac MD, US
International Classification:
A61K 39/395
US Classification:
424144100
Abstract:
CD16A binding proteins useful for the reduction of a deleterious immune response are described. In one aspect, humanized anti-CD16A antibodies, optionally lacking effector function, are used for treatment of immune disorders such as idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia.